Topic Small Cell Lung Cancer
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pembrolizumab With Etoposide/Platinum for First-line Small Cell lung Cancer
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1122Published: November 2022Expires: 10/31/2024Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Small Cell Lung Cancer -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pembrolizumab With Etoposide/Platinum for First-line Small Cell lung Cancer ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN1122Published: November 2022Expires: 10/31/2024Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Small Cell Lung Cancer